ENDOSURE TEST Declared a Revolutionary Diagnostic Tool in the Battle against Endometriosis
Leah Hird • August 7, 2025


The ENDOSURE TEST was recently featured in a prominent medical blog written by Mr. Nicholas Morris of Rapid Access Gynaecology, based in London.  


The article gives an excellent overview of the history of endometriosis, beginning with its dark history as a presumed psychological condition to its modern-day clinical description as a chronic, physical medical condition. With the invention of the Tier-1 ENDOSURE TEST in 2022, Mr. Morris acknowledges the TEST has ushered in what he describes as “a new chapter in the diagnosis of endometriosis.”   


As the only non-invasive, highly accurate, 30-minute, Tier-1 test for endometriosis, the ENDOSURE TEST empowers physicians to detect endometriosis at its earliest stages and offer targeted, personalized therapy to their patients. It effectively shortens the diagnostic timeline from an average of 8.6 years to less than an hour. The TEST empowers patients too, because they no longer must wait nearly a decade before ever knowing what is wrong, offering hope to any woman at any age afflicted with this horrible disease. 


Read Mr. Morris’ full article here: 

The Wonders of Endosure: A Novel Diagnostic Tool for Endometriosis | Rapid Access Gynaecology 


If you think you have endometriosis, talk to your healthcare provider. 

 

Learn more about the ENDOSURE TEST


Woman with endometriosis
By Mark Noar July 7, 2026
EndoSure is proud to announce the NIC published draft guidance recommending the EndoSure test for use in the NHS to speed up endometriosis diagnosis.
EndoSure CE Marking for commercial use in the EU
By Mark Noar April 15, 2026
EndoSure announces that its ENDOSURE TEST has received CE Marking for commercial use in the European Union. This is a huge milestone to help women.